Rallybio to Present at the Jefferies Healthcare Conference

Your unfiltered news center. ®

The world you see depends upon the news you get. ®

HOME

ARTS

RSS

Today's Date: April 18, 2024

OutKick Continues to See Growth in Q1 of 2024 • The DFB (Deutscher Fussball Bund) is partnering with Global Soccer Development to launch unequaled Soccer Camp Opportunities for • AISHA BOWE NAMED STEM FOR HER'S WOMAN OF THE YEAR 2024 • The Nasdaq Entrepreneurial Center Launches Level Up Tool • Battelle Innovations in Climate Resilience Conference to Convene Powerhouse Group of Climate Leaders from the White House, Depar • New Jersey Resources Board of Directors Declares Quarterly Dividend • AARP NY & NYS ATTORNEY GENERAL KICK OFF 'FIGHT FRAUD. SHRED IT!' FREE EVENTS • Avangrid Launches Lineworker Recruitment Efforts to Mark Lineworker Appreciation Day • Memorial and Solis Mammography Open New Community-Based Breast Imaging Centers in Weston, Plantation and Hialeah • American Indian College Fund President Cheryl Crazy Bull Contributing Writer to Book Honoring Legacy of Vine Deloria, Jr. • University of Arizona Women's Basketball Coach Adia Barnes Joins MADD Sports • OKI Group Revises OKI Group Environmental Vision 2030/2050 • PPG highlights 2023 performance during annual meeting of shareholders • Introducing iSports at iCode: A Cutting-Edge Esports Program for Aspiring Gamers • American Seafoods, Preeminent Fishing Leader in Sustainable Proteins, Releases Annual Sustainability Report • Greasecycle Founder and President Selected as North Carolina's Small Business Person of the Year • Proemion Holding GmbH Agrees to Acquire TrendMiner NV to Expand Industrial Asset-Monitoring and Analytics Platform • U.S. News and the Global Black Economic Forum Announce Partnership to Advance Equity and Economic Opportunity for All • Outdoor Education Capturing Attention, Inspiring South Canton Scholars • Williams to Volunteer at nearly 100 Community Projects Across 17 States

Rallybio to Present at the Jefferies Healthcare Conference

NEW HAVEN, Conn. , June 01 /Businesswire/ - Rallybio Corporation (Nasdaq: RLYB), a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today announced that Company management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 9 at 9:00AM ET in New York, NY.

A live webcast of the fireside chat will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. An archived replay of the webcast will be available for 30 days following the presentation.

About Rallybio

Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, a C5 complement inhibitor with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development.

Rallybio is headquartered in New Haven, Connecticut with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut. For more information, please visit www.rallybio.com and follow us on LinkedIn.